![](/img/cover-not-exists.png)
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia
Pich, A, Riera, L, Sismondi, F, Godio, L, Bonino, L D., Marmont, F, di Celle, P F.Volume:
62
Language:
english
Journal:
Journal of Clinical Pathology
DOI:
10.1136/jcp.2009.065904
Date:
September, 2009
File:
PDF, 929 KB
english, 2009